This is a preview of subscription content, log in via an institution to check access.
Reference
Nasser SC, et al. Cost-effectiveness of novel treatment of hepatitis C virus in Lebanese patients. International Journal of Clinical Pharmacy : 2 Apr 2018. Available from: URL: http://doi.org/10.1007/s11096-018-0628-6
Rights and permissions
About this article
Cite this article
DAAs cost effective for early-stage hepatitis C in Lebanon. PharmacoEcon Outcomes News 801, 12 (2018). https://doi.org/10.1007/s40274-018-4867-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4867-5